Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
about
Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoidSynthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugatesSynthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoidOligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in micePhase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice.Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid.Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetylsSafety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sitesEffect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice.Simplest identification, O-specific polysaccharide purification and antigenic evaluation of Salmonella enterica serovar Typhi Vi negative isolateO:2-CRM(197) conjugates against Salmonella Paratyphi A.Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine componentSaccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.Progress and pitfalls in Shigella vaccine research.Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain lengthPurification and antigenic detection of O-specific polysaccharides of Salmonella enterica serovar Paratyphi A isolate from Pakistan: an emerging threat.A scalable method for O-antigen purification applied to various Salmonella serovars.Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making
P2860
Q28343287-C29BBCDB-BBA5-4D78-BA7D-4DF9890D8542Q30328099-A546BD9A-6DBC-4450-BE53-6C81FC5DA911Q33577920-9E5343B3-3D11-430A-B98F-1CD41A80D945Q33595722-A3ACF085-9477-4A6B-BC40-F6F92297AA25Q33607442-1AC0C027-D7B0-4716-BD60-FA14ACB2D322Q33835015-FAB508C1-8764-4F80-972E-148DC40C0E5EQ34002272-D75827EC-BE55-47B4-9C57-270F396A87C8Q34003647-F4A83DAB-3FFD-45C5-B1FE-737B6027EEB7Q34003957-C0917A74-7359-4EB2-9EB1-C3FD48A4D16EQ35099146-F0B0F88E-1C3E-4439-88D0-5CEF6E780CC6Q35227169-12C420C4-84F6-4360-AC38-1CE7139818F2Q35270721-8484CC3C-0456-4633-B978-54A3015A35A2Q35425792-325EF8A0-69F7-41F8-A847-073FA9401FC0Q35505761-5D189EB2-EC9F-4362-8EFD-6AD675431221Q35523144-CA1F03B2-E99A-434F-B3C2-3DC5EC03CFBFQ35548702-986F418D-4A42-4FE0-A11A-AE6B2D7F99A2Q35771562-446175CF-C76F-4C15-BDCB-696755B13AE8Q35887055-1624322D-BE0B-46B0-868A-4C3852F699EAQ35913681-129D07D4-3BE5-4AD7-8C16-C733831DA3DDQ35955978-4B48A52B-397B-4DB9-92F6-C88ABA573462Q36294524-DA821CC1-CDC2-4F69-9551-1853A6C52D05Q36380921-894583B7-18C4-4579-B645-7C55A0B79AD4Q36735285-B8E24238-B744-4FD2-BC17-1EB2C9CE265EQ36842967-32FFAAC2-B062-4BF5-A2FE-E135C9976A0EQ36949262-CFDB04B0-1B5D-4535-BDA0-ADEAE33E177EQ36970577-94028D22-0241-4CD8-8904-E93A3512AC49Q37105553-4C75D1B2-4B72-44E9-8F0D-A56E56148D44Q37340450-5D4AB958-9F58-4B8B-8101-4C82DF3FBACCQ37407888-2117332A-2FEF-44B6-AA74-647190D84086Q38538720-E47887D2-02ED-461C-B93C-8A3F30B418BFQ58375482-D701AD05-783B-445C-B78A-951A65A44AB3
P2860
Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Preparation, characterization, ...... llus) bound to tetanus toxoid.
@en
type
label
Preparation, characterization, ...... llus) bound to tetanus toxoid.
@en
prefLabel
Preparation, characterization, ...... llus) bound to tetanus toxoid.
@en
P2093
P2860
P1476
Preparation, characterization, ...... illus) bound to tetanus toxoid
@en
P2093
Robbins JB
Schneerson R
Shiloach J
P2860
P304
P407
P577
1991-12-01T00:00:00Z